Seres Therapeutics shares owned by Bridgeway Capital Management
Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Bridgeway Capital Management
from 13F filings
Historical chart of Bridgeway Capital Management investment in Seres Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Seres Therapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Seres Therapeutics by Bridgeway Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $208k | 250k | 0.83 |
2024-09-30 | $237k | 250k | 0.95 |
2024-03-31 | $116k | 150k | 0.77 |
2020-03-31 | $257k | 72k | 3.56 |
2019-09-30 | $612k | 153k | 4.01 |
2019-06-30 | $469k | 146k | 3.22 |
2019-03-31 | $1000k | 146k | 6.87 |
More positions owned by Bridgeway Capital Management
View all positions for Bridgeway Capital Management